Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.

The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.

The Bimbo and Femsa-backed online grocer has now received over $100m in total, having raised $65m from venture capital investors for its series A round.

GV returned for SpyBiotech's $32.5m series A round, as it looks to move its first potential vaccine into the clinic by early next year.

China Merchants Group participated in a series C-plus round for the cancer and inflammatory disease drug developer.

The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.

Optum Ventures returned to invest in the telehealth software developer’s series A round, which was led by Venrock.

The Telus Ventures-backed debt recovery software provider has secured over $100m in total, Inovia Capital having led its series B-plus round.

Several automotive manufacturers backed a series C3 round taking the AI chip developer's funding to $900m in the past two months.

Oko Markets was among the backers in a $1.9m close of the logistics technology developer’s series B round, which already included Emtek, EV Growth and SoftBank Ventures Asia.